Apparatus for measuring the temperature of a piston in an internal combustion engine

An apparatus for measuring the temperature of a piston in an internal combustion engine. The apparatus includes a thermistor to sense the temperature of the piston and generate an electrical signal representative of that temperature, a transmission unit connected to the thermistor for receiving the electrical signal and for converting the signal to an infrared beam for transmission to a point remote from the piston, and a receiver to receive the beam and convert the beam to an electrical signal corresponding to the electrical signal generated by the thermistor. The first mentioned electrical signal is converted to a rectangular wave form prior to transmission of the infrared beam.https://digitalcommons.mtu.edu/patents/1082/thumbnail.jp

Rotational torque measurement device

A device for measuring torque applied through a rotating member. A first torsion reference member is fixedly coupled to the rotating member at a first axial position and a second torsion reference member is fixedly coupled to the rotating member at a second axial position. A first detector detects the passage of the first torsion reference member past the first detector upon each full rotation of the rotating member and to generate a first signal upon each passage of the first torsion reference member. A second detector detects the passage of the second torsion reference member past the second detector upon each full rotation of the rotating member and to generate a second signal upon each passage of the second torsion reference member. A controller calculates a phase difference between the first signal and the second signal relative during rotation of the rotating member under a torsional load.https://digitalcommons.mtu.edu/patents/1003/thumbnail.jp

Microwave telemetry for sensing conditions in enclosed rotating and/or reciprocating machinery

An apparatus for measuring the pressure within the torque converter of an automatic transmission. The apparatus includes a sensor to sense the interior pressure of the torque converter and generate an electrical signal representative of that pressure. That signal is converted to microwave energy which is radiated into the interior of the torque converter housing from a microwave transmitter located within the torque converter. Receiving microwave antennae exposed to the housing interior receive the microwaves and transmit an electrical signal corresponding to the microwave energy to a remote readout external of the torque converter. The receiving antenna are preferably in the form of resonant slots in the torque converter housing and the slots have a length related to the wavelength of the generated microwaves.https://digitalcommons.mtu.edu/patents/1069/thumbnail.jp

Comparison of piston temperature measurement methods: Templugs versus wireless telemetry with thermocouples

The objective of this investigation was to compare the results of metallurgical temperature sensors and thermocouples when used to measure piston temperatures in a running engine. Type J thermocouples and a microwave wireless telemetry system were used to gather real time temperature data on the piston in the vicinity of each metallurgical sensor. Eight pairs of metallurgical temperature sensors were installed in the piston with a thermocouple junction in-between. The engine was ramped up to steady state quickly and then held for approximately 4h at 1800 rpm and 1980Nm before being quickly ramped back down in accordance with the metallurgical sensors\u27 recommended test cycle. During the test, continuous temperature data at each of the sensor locations were monitored and recorded using the telemetry system. After the test was complete, the metallurgical temperature sensors were removed and independently analyzed. The results indicate that readings from the metallurgical temperature sensors were similar to those of the embedded thermocouples for locations without large thermal gradients. However, when thermal gradients were present, the metallurgical sensor\u27s reading was influenced measurably. Copyright © 2013 by ASME

Comparison of piston temperature measurement methods: Templugs versus wireless telemetry with thermocouples

The objective of this investigation was to compare the results of metallurgical temperature sensors and thermocouples when used to measure piston temperatures in a running engine. Type J thermocouples and a microwave wireless telemetry system were used to gather real time temperature data on the piston in the vicinity of each metallurgical sensor. Eight pairs of metallurgical temperature sensors were installed in the piston with a thermocouple junction in-between. The engine was ramped up to steady state quickly and then held for approximately four hours at 1800 RPM and 1980 N-m before being quickly ramped back down in accordance with the metallurgical sensors\u27 recommended test cycle. During the test, continuous temperature data at each of the sensor locations was monitored and recorded using the telemetry system. After the test was complete, the metallurgical temperature sensors were removed and independently analyzed. The results indicate that readings from the metallurgical temperature sensors were similar to those of the embedded thermocouples for locations without large thermal gradients. However, when thermal gradients were present, the metallurgical sensor\u27s reading was influenced measurably. Copyright © 2012 by ASME

A wireless microwave telemetry data transfer technique for reciprocating and rotating components

Wireless microwave telemetry addresses the difficult issue of obtaining transducer outputs from reciprocating and rotating components through the use of advanced electronic components. This eliminates the requirements of a direct link between the transducer and the acquisition system. Accuracy of the transducer signal is maintained through the use of a doublefrequency modulation technique which provides temperature stability and a 20 point calibration of the complete system. Multiple transmitters can be usedfor larger applications and multiple antennas can be used to improve the signal strength and reduce the possibility of dropouts. Examples of automotive torque converter and piston temperature measurements are provided, showing the effectiveness of the wireless measuring technique. Copyright © 2008 by ASME

Apixaban versus warfarin in patients with atrial fibrillation

BACKGROUND: Vitamin K antagonists are highly effective in preventing stroke in patients with atrial fibrillation but have several limitations. Apixaban is a novel oral direct factor Xa inhibitor that has been shown to reduce the risk of stroke in a similar population in comparison with aspirin. METHODS: In this randomized, double-blind trial, we compared apixaban (at a dose of 5 mg twice daily) with warfarin (target international normalized ratio, 2.0 to 3.0) in 18,201 patients with atrial fibrillation and at least one additional risk factor for stroke. The primary outcome was ischemic or hemorrhagic stroke or systemic embolism. The trial was designed to test for noninferiority, with key secondary objectives of testing for superiority with respect to the primary outcome and to the rates of major bleeding and death from any cause. RESULTS: The median duration of follow-up was 1.8 years. The rate of the primary outcome was 1.27% per year in the apixaban group, as compared with 1.60% per year in the warfarin group (hazard ratio with apixaban, 0.79; 95% confidence interval [CI], 0.66 to 0.95; P<0.001 for noninferiority; P = 0.01 for superiority). The rate of major bleeding was 2.13% per year in the apixaban group, as compared with 3.09% per year in the warfarin group (hazard ratio, 0.69; 95% CI, 0.60 to 0.80; P<0.001), and the rates of death from any cause were 3.52% and 3.94%, respectively (hazard ratio, 0.89; 95% CI, 0.80 to 0.99; P = 0.047). The rate of hemorrhagic stroke was 0.24% per year in the apixaban group, as compared with 0.47% per year in the warfarin group (hazard ratio, 0.51; 95% CI, 0.35 to 0.75; P<0.001), and the rate of ischemic or uncertain type of stroke was 0.97% per year in the apixaban group and 1.05% per year in the warfarin group (hazard ratio, 0.92; 95% CI, 0.74 to 1.13; P = 0.42). CONCLUSIONS: In patients with atrial fibrillation, apixaban was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding, and resulted in lower mortality. Copyright © 2011 Massachusetts Medical Society. All rights reserved

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of the ARISTOTLE trial

Background: In the ARISTOTLE trial, the rate of stroke or systemic embolism was reduced by apixaban compared with warfarin in patients with atrial fibrillation (AF). Patients with AF and previous stroke or transient ischaemic attack (TIA) have a high risk of stroke. We therefore aimed to assess the efficacy and safety of apixaban compared with warfarin in prespecified subgroups of patients with and without previous stroke or TIA. Methods: Between Dec 19, 2006, and April 2, 2010, patients were enrolled in the ARISTOTLE trial at 1034 clinical sites in 39 countries. 18 201 patients with AF or atrial flutter were randomly assigned to receive apixaban 5 mg twice daily or warfarin (target international normalised ratio 2·0-3·0). The median duration of follow-up was 1·8 years (IQR 1·4-2·3). The primary efficacy outcome was stroke or systemic embolism, analysed by intention to treat. The primary safety outcome was major bleeding in the on-treatment population. All participants, investigators, and sponsors were masked to treatment assignments. In this subgroup analysis, we estimated event rates and used Cox models to compare outcomes in patients with and without previous stroke or TIA. The ARISTOTLE trial is registered with ClinicalTrials.gov, number NTC00412984. Findings: Of the trial population, 3436 (19%) had a previous stroke or TIA. In the subgroup of patients with previous stroke or TIA, the rate of stroke or systemic embolism was 2·46 per 100 patient-years of follow-up in the apixaban group and 3·24 in the warfarin group (hazard ratio [HR] 0·76, 95% CI 0·56 to 1·03); in the subgroup of patients without previous stroke or TIA, the rate of stroke or systemic embolism was 1·01 per 100 patient-years of follow-up with apixaban and 1·23 with warfarin (HR 0·82, 95% CI 0·65 to 1·03; p for interaction=0·71). The absolute reduction in the rate of stroke and systemic embolism with apixaban versus warfarin was 0·77 per 100 patient-years of follow-up (95% CI -0·08 to 1·63) in patients with and 0·22 (-0·03 to 0·47) in those without previous stroke or TIA. The difference in major bleeding with apixaban compared with warfarin was 1·07 per 100 patient-years (95% CI 0·09-2·04) in patients with and 0·93 (0·54-1·32) in those without previous stroke or TIA. Interpretation: The effects of apixaban versus warfarin were consistent in patients with AF with and without previous stroke or TIA. Owing to the higher risk of these outcomes in patients with previous stroke or TIA, the absolute benefits of apixaban might be greater in this population. Funding: Bristol-Myers Squibb and Pfizer. © 2012 Elsevier Ltd